| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Investing > France Better Than Spain - Safer Than Eastern Europe |
|
Top Adding - France Better Than Spain - Safer Than Eastern Europe
France is a better place to invest in than Spain and less risky than eastern European cou According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ntries, according to one expert. s Trisha Mason, managing director of property firm VEF, ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in said that the Spanish market had "fallen flat on its face" and that more people should l lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ok to buying French property instead. She added that while it was true that the French p here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe roperty market may not match the capital growth seen in places such as Bulgaria, it is ce d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rtainly a safer choice than any of these countries. Investors take advantage of ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc mature economy' "France is good because it's a mature economy, it's a safe prop easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi erty market but it's not going to produce the capital growth that some eastern countries nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically do," said Ms Mason. "[France is] a safe choice, but it's more interesting this month tha and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ it was last month." She added that the French economy was set to boom under the new pre ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sident Nicolas Sarkozy and that there was plenty of time for investor to cash in before h ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ouse prices start rising. Property market gets lively with Sarkozy The dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod property market is predicted to get "livelier" with the arrival of the politician, who is cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin said to be intending to lower inheritance tax, and make mortgages more tax efficient. A tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nother bonus Mr Sarkozy brings with him is the pledge to cut the red tape surrounding buy t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ng property and investing in France. Although the Sarkozy effect could take some time to ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust manifest itself, and there is likely to be some resistance from the Unions, it could be y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products a good time to start looking! We recommend the . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de .co.uk/property/region/Languedoc-Roussillon/index.php?ss=Languedoc%20-%20Roussillon&tt=Fr elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ance&var1=mls&var=state" target="_blank">Languedoc-Roussillon for property investment tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Get a Home Loan if You’ve Been Bankrupted
|